Cargando…

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial

BACKGROUND: Mevidalen is a selective positive allosteric modulator (PAM) of the dopamine D1 receptor subtype. OBJECTIVE: To assess the safety and efficacy of mevidalen for treatment of cognition in patients with Lewy body dementia (LBD). METHODS: PRESENCE was a phase 2, 12‐week study in participants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biglan, Kevin, Munsie, Leanne, Svensson, Kjell A., Ardayfio, Paul, Pugh, Melissa, Sims, John, Brys, Miroslaw
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300146/ https://www.ncbi.nlm.nih.gov/pubmed/34859493 http://dx.doi.org/10.1002/mds.28879

Ejemplares similares

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor–Positive Allosteric Modulator, in Patients With Parkinson Disease
por: Wilbraham, Darren, et al.
Publicado: (2021)

Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
por: Battioui, Chakib, et al.
Publicado: (2023)

Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor‐Positive Allosteric Modulator (D1PAM), in Healthy Subjects
por: Wilbraham, Darren, et al.
Publicado: (2020)

Evaluating the Use of Digital Biomarkers to Test Treatment Effects on Cognition and Movement in Patients with Lewy Body Dementia
por: Wang, Jian, et al.
Publicado: (2022)

Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression
por: van de Beek, Marleen, et al.
Publicado: (2020)

Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
por: Chen, Qin, et al.
Publicado: (2022)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials
por: Goldman, Jennifer G., et al.
Publicado: (2020)

Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting
por: Goldman, Jennifer G., et al.
Publicado: (2021)

Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer's disease
por: Schumacher, Julia, et al.
Publicado: (2019)

Correlation of microglial activation with white matter changes in dementia with Lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Divergent brain functional network alterations in dementia with Lewy bodies and Alzheimer's disease
por: Peraza, Luis R., et al.
Publicado: (2015)

Premotor and fronto-striatal mechanisms associated with presence hallucinations in dementia with Lewy bodies
por: Nicastro, Nicolas, et al.
Publicado: (2021)

Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography
por: Perovnik, Matej, et al.
Publicado: (2022)

Disease Progression and Longitudinal Clinical Outcomes of Lewy Body Dementia in the NACC Database
por: Chandler, Julie, et al.
Publicado: (2022)

Plasma Phospho‐Tau Identifies Alzheimer's Co‐Pathology in Patients with Lewy Body Disease
por: Hall, Sara, et al.
Publicado: (2020)

The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
por: García‐Sanz, Patricia, et al.
Publicado: (2020)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

fMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies
por: Peraza, Luis R., et al.
Publicado: (2014)

Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies()
por: Bonanni, Laura, et al.
Publicado: (2015)

Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2015)

The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies
por: Abdelnour, Carla, et al.
Publicado: (2020)

Reorganization of rich clubs in functional brain networks of dementia with Lewy bodies and Alzheimer’s disease
por: Ma, Wen-ying, et al.
Publicado: (2021)

RT‐QuIC Detection of Pathological α‐Synuclein in Skin Punches of Patients with Lewy Body Disease
por: Mammana, Angela, et al.
Publicado: (2021)

Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
por: Mori, Etsuro, et al.
Publicado: (2012)

Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study
por: Wolters, E.E., et al.
Publicado: (2020)

A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease
por: Thomas, Alan J., et al.
Publicado: (2022)

Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases
por: Soto, Marta, et al.
Publicado: (2022)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Imaging tau burden in dementia with Lewy bodies using [(18)F]-AV1451 positron emission tomography
por: Mak, Elijah, et al.
Publicado: (2021)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An (123)I-FP-CIT SPECT study
por: van der Zande, J.J., et al.
Publicado: (2019)

Topography of cortical thinning in the Lewy body diseases
por: Ye, Rong, et al.
Publicado: (2020)

A proteomic signature for dementia with Lewy bodies
por: O'Bryant, Sid E., et al.
Publicado: (2019)

Differences in the Experience of Caregiving Between Spouse and Adult Child Caregivers in Dementia With Lewy Bodies
por: Rigby, Taylor, et al.
Publicado: (2019)

Safety, target engagement, and biomarker effects of bosutinib in dementia with Lewy bodies
por: Pagan, Fernando L., et al.
Publicado: (2022)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o6e5bdo19nokb5aemkpl2pgvvo